Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry

Respirology

Volumn 22, Issue 5, 2017, Pages 950-956

  Glaspole, Ian N ^a,b   Chapman, Sally A ^c   Cooper, Wendy A ^d,e,f   Ellis, Samantha J ^a   Goh, Nicole S ^a,g   Hopkins, Peter M ^h   Macansh, Sacha ⁱ   Mahar, Annabelle ^d,e   Moodley, Yuben P ^j   Paul, Eldho ^a,b   Reynolds, Paul N ^c   Walters, E Haydn ^k   Zappala, Christopher J ^l   Corte, Tamera J ^d,m  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF WESTERN SYDNEY   (Australia)

^g AUSTIN HOSPITAL   (Australia)

^h THE PRINCE CHARLES HOSPITAL   (Australia)

ⁱ Lung Foundation Australia   (Australia)

^j FIONA STANLEY HOSPITAL   (Australia)

^k UNIVERSITY OF TASMANIA   (Australia)

^l ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^m UNIVERSITY OF SYDNEY   (Australia)

more..

Author keywords

cough; dyspnoea; forced vital capacity; pulmonary fibrosis; quality of life

Indexed keywords

OXYGEN;

AGED; ARTICLE; CAUSE OF DEATH; CLINICAL FEATURE; COMORBIDITY; COUGHING; DEMOGRAPHY; DEPRESSION; DISEASE REGISTRY; DISEASE SEVERITY; DYSPNEA; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MORTALITY RISK; PHYSIOLOGICAL PROCESS; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOM; UNIVERSITY OF CALIFORNIA SAN DIEGO SHORTNESS OF BREATHLESSNESS QUESTIONNAIRE; VISUAL ANALOG SCALE; AUSTRALIA; COMPLICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PSYCHOLOGY; REGISTER; STATISTICAL MODEL; VITAL CAPACITY;

AGED; AUSTRALIA; COUGH; DEPRESSION; DYSPNEA; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUALITY OF LIFE; REGISTRIES; SURVEYS AND QUESTIONNAIRES; VITAL CAPACITY;

EID: 85013130903     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12989     Document Type: Article

References (26)

1. Swigris JJ, Fairclough D. Patient-reported outcomes in idiopathic pulmonary fibrosis research. Chest 2012; 142: 291–7.
2. Russell AM, Sprangers MA, Wibberley S, Snell N, Rose DM, Swigris JJ. The need for patient-centred clinical research in idiopathic pulmonary fibrosis. BMC Med. 2015; 13: 240.
3. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L et al.; ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 2014; 370: 2083–92.
4. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2014; 370: 2071–82.
5. Peng S, Li Z, Kang J, Hou X. Cross-sectional and longitudinal construct validity of the Saint George's Respiratory Questionnaire in patients with IPF. Respirology 2008; 13: 871–9.
6. Swigris JJ, Brown KK, Behr J, du Bois RM, King TE, Raghu G, Wamboldt FS. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir. Med. 2010; 104: 296–304.
7. Olson AL, Brown KK, Swigris JJ. Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis. Patient Relat. Outcome Meas. 2016; 7: 29–35.
8. Belkin A, Swigris JJ. Health-related quality of life in idiopathic pulmonary fibrosis: where are we now? Curr. Opin. Pulm. Med. 2013; 19: 474–9.
9. Swigris JJ, Kuschner WG, Jacobs SS, Wilson SR, Gould MK. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 2005; 60: 588–94.
10. De Vries J, Seebregts A, Drent M. Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used? Respir. Med. 2000; 94: 273–8.
11. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE Jr; Idiopathic Pulmonary Fibrosis Study Group. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 2004; 350: 125–33.
12. Moodley Y, Goh N, Glaspole I, Macansh S, Walters EH, Chapman S, Hopkins P, Reynolds PN, Zappala C, Cooper W et al.; Australian IPF Registry Steering Committee. Australian Idiopathic Pulmonary Fibrosis Registry: vital lessons from a national prospective collaborative project. Respirology 2014; 19: 1088–91.
13. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am. Rev. Respir. Dis. 1992; 145: 1321–7.
14. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 1983; 67: 361–70.
15. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest 1998; 113: 619–24.
16. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur. Respir. J. Suppl. 1993; 16: 5–40.
17. Gulsvik A, Bakke P, Humerfelt S, Omenaas E, Tosteson T, Weiss ST, Speizer FE. Single breath transfer factor for carbon monoxide in an asymptomatic population of never smokers. Thorax 1992; 47: 167–73.
18. Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann. Intern. Med. 2012; 156: 684–91.
19. Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG, Colby TV, du Bois RM, Hansell DM. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am. J. Respir. Crit. Care Med. 2003; 167: 962–9.
20. Snaith RP. The Hospital Anxiety and Depression Scale. Health Qual. Life Outcomes 2003; 1: 29.
21. Swigris JJ, Han M, Vij R, Noth I, Eisenstein EL, Anstrom KJ, Brown KK, Fairclough D. The UCSD Shortness of Breath Questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis. Respir. Med. 2012; 106: 1447–55.
22. Yorke J, Jones PW, Swigris JJ. Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire. Thorax 2010; 65: 921–6.
23. Yorke J, Spencer LG, Duck A, Ratcliffe S, Kwong GN, Longshaw MS, Belkin A, Swigris JJ. Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA). BMJ Open Respir. Res. 2014; 1: e000024.
24. Patel AS, Siegert RJ, Brignall K, Gordon P, Steer S, Desai SR, Maher TM, Renzoni EA, Wells AU, Higginson IJ et al. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax 2012; 67: 804–10.
25. Walsh SL, Wells AU, Desai SR, Poletti V, Piciucchi S, Dubini A, Nunes H, Valeyre D, Brillet PY, Kambouchner M et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir. Med. 2016; 4: 557–65.
26. Swigris JJ, Esser D, Conoscenti CS, Brown KK. The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review. Health Qual. Life Outcomes 2014; 12: 124.